<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>MYA Space | Mejia Bright | Activity</title>
	<link>https://space.mya.co.uk/members/judocotton4/activity/</link>
	<atom:link href="https://space.mya.co.uk/members/judocotton4/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Mejia Bright.</description>
	<lastBuildDate>Mon, 21 Sep 2026 15:35:39 +0100</lastBuildDate>
	<generator>https://buddypress.org/?v=10.2.0</generator>
	<language>en-GB</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">e1783173804e1309ef7cf8e5693ffa4e</guid>
				<title>Mejia Bright posted an update: The cost-effectiveness associated with TDM along with IM [&#133;]</title>
				<link>https://space.mya.co.uk/activity/p/1653005/</link>
				<pubDate>Mon, 16 Oct 2023 08:07:38 +0100</pubDate>

									<content:encoded><![CDATA[<p>The cost-effectiveness associated with TDM along with IM (I&#8217;m TDM) within first-line CML treatment method hasn&#8217;t yet been recently studied. Aims To ascertain the cost-effectiveness associated with I am TDM for the first-line treating CML in comparison to tyrosine kinase inhibitor merely treatment. Strategies Any lately posted cost-effectiveness&hellip;<span class="activity-read-more" id="activity-read-more-1653005"><a href="https://space.mya.co.uk/activity/p/1653005/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">b5673c195465fc0cd5c2691f22d4edae</guid>
				<title>Mejia Bright posted an update: The novel Etoposide mw explanation associated with METRNL [&#133;]</title>
				<link>https://space.mya.co.uk/activity/p/1638297/</link>
				<pubDate>Sun, 15 Oct 2023 08:42:20 +0100</pubDate>

									<content:encoded><![CDATA[<p>The novel <a href="https://www.selleckchem.com/products/Etopophos.html" rel="nofollow ugc">Etoposide mw</a> explanation associated with METRNL and also KLF3 since hepatokines could pave the right way to target their manufacturing and/or signaling throughout obesity, NAFLD, as well as related issues. Equally healthy proteins might act as possible biomarkers to appraisal weight reduction following weight loss surgery.The book&hellip;<span class="activity-read-more" id="activity-read-more-1638297"><a href="https://space.mya.co.uk/activity/p/1638297/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">b3980a7d9c23ee686ba3981a4e317e3b</guid>
				<title>Mejia Bright became a registered member</title>
				<link>https://space.mya.co.uk/activity/p/1638124/</link>
				<pubDate>Sun, 15 Oct 2023 08:26:38 +0100</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>
<!--
Performance optimized by W3 Total Cache. Learn more: https://www.boldgrid.com/w3-total-cache/

Object Caching 0/128 objects using Redis
Page Caching using Disk: Enhanced 
Lazy Loading
Database Caching using Redis (Request-wide modification query)

Served from: space.mya.co.uk @ 2026-09-21 16:57:05 by W3 Total Cache
-->